Rasuvo

Active Ingredient(s): Methotrexate
FDA Approved: * July 10, 2014
Pharm Company: * MEDAC PHARMA INC
Category: Cancer

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant.[4] It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions.[4] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma.[4] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rasuvo 7.5 mg/.15ml Subcutaneous Injection, Solution
NDC: 59137-505
Labeler:
Medac Pharma, Inc
Rasuvo 10 mg/.2ml Subcutaneous Injection, Solution
NDC: 59137-510
Labeler:
Medac Pharma, Inc
Rasuvo 12.5 mg/.25ml Subcutaneous Injection, Solution
NDC: 59137-515
Labeler:
Medac Pharma, Inc
Rasuvo 15 mg/.3ml Subcutaneous Injection, Solution
NDC: 59137-520
Labeler:
Medac Pharma, Inc
Rasuvo 17.5 mg/.35ml Subcutaneous Injection, Solution
NDC: 59137-525
Labeler:
Medac Pharma, Inc
Rasuvo 20 mg/.4ml Subcutaneous Injection, Solution
NDC: 59137-530
Labeler:
Medac Pharma, Inc
Rasuvo 22.5 mg/.45ml Subcutaneous Injection, Solution
NDC: 59137-535
Labeler:
Medac Pharma, Inc
Rasuvo 25 mg/.5ml Subcutaneous Injection, Solution
NDC: 59137-540
Labeler:
Medac Pharma, Inc
Rasuvo 27.5 mg/.55ml Subcutaneous Injection, Solution
NDC: 59137-545
Labeler:
Medac Pharma, Inc
Rasuvo 30 mg/.6ml Subcutaneous Injection, Solution
NDC: 59137-550
Labeler:
Medac Pharma, Inc

Popular Topics

Rasuvostatin

what is rasuvastatin...